Diabetes Care · 2003 · 253 citations · 21 references
Decreasing mean HbA(1c) and BP levels and the wider use of lipid-lowering drugs during the late 1990s in patients with diabetes in a national sample from Sweden should translate into clinical benefits regarding micro- and macrovascular complications as well as diabetes-related mortality.
21
R. C. Turner, Charles Fox, Matthews et al. · The Lancet · 1998 · 8.4K citations
Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +10